Cargando…
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
Although treatment for advanced epithelial ovarian cancer has improved over recent years with the introduction of taxane–platinum chemotherapy, the majority of patients will relapse, and in most the disease remains incurable. A thorough understanding of drug resistance mechanisms is needed, as this...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750620/ https://www.ncbi.nlm.nih.gov/pubmed/14661043 http://dx.doi.org/10.1038/sj.bjc.6601497 |